These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15867217)

  • 21. [Role of vascular endothelial growth factor overexpression in ovarian tumor invasion and mechanism].
    Lu Y; Zhang A; Wang S; Li J; Wang C; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2002 May; 37(5):294-7. PubMed ID: 12133405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis.
    Zu X; Tang Z; Li Y; Gao N; Ding J; Qi L
    BJU Int; 2006 Nov; 98(5):1090-3. PubMed ID: 17034609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression level of vascular endothelial growth factor-C and -A in cultured human oral squamous cell carcinoma correlates respectively with lymphatic metastasis and angiogenesis when transplanted into nude mouse oral cavity.
    Nakazato T; Shingaki S; Kitamura N; Saito C; Kuwano R; Tachibana M
    Oncol Rep; 2006 Apr; 15(4):825-30. PubMed ID: 16525666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
    Mylona E; Alexandrou P; Mpakali A; Giannopoulou I; Liapis G; Markaki S; Keramopoulos A; Nakopoulou L
    Eur J Surg Oncol; 2007 Apr; 33(3):294-300. PubMed ID: 17129704
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
    Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA
    Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
    Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
    Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression and clinical significance of vascular endothelial growth factor C and D in nasopharyngeal carcinoma].
    Zhao GG; Xiang XJ; He YJ
    Ai Zheng; 2007 Jan; 26(1):90-5. PubMed ID: 17222375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
    Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
    Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
    Soumaoro LT; Uetake H; Takagi Y; Iida S; Higuchi T; Yasuno M; Enomoto M; Sugihara K
    Dis Colon Rectum; 2006 Mar; 49(3):392-8. PubMed ID: 16474989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expressions of vascular endothelial growth factor C and matrix metalloproteinases-2 and prognosis of non-small cell lung carcinoma].
    Zhang HZ; Wei YP; Li HG; Wang M; Liu JG; Wu C
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1307-10. PubMed ID: 16982442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the antiangiogenic effect of Taxol in a human epithelial ovarian carcinoma cell line.
    Hata K; Osaki M; Dhar DK; Nakayama K; Fujiwaki R; Ito H; Nagasue N; Miyazaki K
    Cancer Chemother Pharmacol; 2004 Jan; 53(1):68-74. PubMed ID: 14569416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression.
    Kim SH; Cho NH; Kim K; Lee JS; Koo BS; Kim JH; Chang JH; Choi EC
    J Surg Oncol; 2006 Mar; 93(4):330-7. PubMed ID: 16496371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VEGF-C, VEGFR-3, and COX-2 enhances growth and metastasis of human cervical carcinoma cell lines in vitro.
    Shi X; Chen G; Xing H; Weng D; Bai X; Ma D
    Oncol Rep; 2007 Jul; 18(1):241-7. PubMed ID: 17549374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma.
    Li L; Liu B; Li X; Yang S; Xiao J; Chen M; Zhang Y; Ma J
    Anat Rec (Hoboken); 2009 Apr; 292(4):562-9. PubMed ID: 19226617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor expression in the basal subtype of breast carcinoma.
    Ribeiro-Silva A; Ribeiro do Vale F; Zucoloto S
    Am J Clin Pathol; 2006 Apr; 125(4):512-8. PubMed ID: 16627261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the vascular endothelial growth factor (VEGF)-C role in urothelial carcinomas of the bladder.
    Mylona E; Magkou C; Gorantonakis G; Giannopoulou I; Nomikos A; Zarogiannos A; Zervas A; Nakopoulou L
    Anticancer Res; 2006; 26(5A):3567-71. PubMed ID: 17094484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of microvessel density by quantitative real-time PCR in esophageal cancer: correlation with histologic methods, angiogenic growth factor expression, and lymph node metastasis.
    Loges S; Clausen H; Reichelt U; Bubenheim M; Erbersdobler A; Schurr P; Yekebas E; Schuch G; Izbicki J; Pantel K; Bokemeyer C; Fiedler W
    Clin Cancer Res; 2007 Jan; 13(1):76-80. PubMed ID: 17200341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas.
    Okada K; Osaki M; Araki K; Ishiguro K; Ito H; Ohgi S
    Anticancer Res; 2005; 25(4):3003-9. PubMed ID: 16080559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
    Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
    BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.